Welcome to our dedicated page for Infusystem Hld news (Ticker: INFU), a resource for investors and traders seeking the latest updates and insights on Infusystem Hld stock.
InfuSystem Holdings, Inc. (NYSE American: INFU) regularly issues news and press releases that are of interest to investors, analysts and others following the health care services and durable medical equipment space. The company describes itself as a national health care service provider that facilitates outpatient care for durable medical equipment manufacturers and health care providers, with operations organized into Patient Services and Device Solutions platforms.
News items about InfuSystem often include quarterly and annual financial results, where the company discusses net revenues, segment performance for Patient Services and Device Solutions, gross margin trends, cash flow, and Adjusted EBITDA. These releases typically highlight how oncology, pain management and wound therapy within Patient Services, as well as rentals, pump and consumable sales, and biomedical services within Device Solutions, have contributed to overall results.
Another common category of news involves guidance and outlook. InfuSystem has used press releases to provide or reaffirm guidance ranges for net revenue growth and Adjusted EBITDA margin for upcoming fiscal years, and to explain how factors such as revenue mix, information technology projects, and capital expenditures may affect margins and cash flow.
The company also issues announcements about leadership changes and corporate governance, such as the CEO transition disclosed in April 2025, and about participation in investor conferences hosted by firms like ROTH and Craig-Hallum. These items often note that management will host one-on-one or small group meetings with investors.
In addition, InfuSystem uses news releases to communicate regulatory and policy developments that affect its business. For example, an 8-K dated December 10, 2025 references a press release announcing that the Centers for Medicare and Medicaid Services added two electronic infusion pumps used in the company’s Pain Management services business to the list of qualifying products for separate payment under the NOPAIN Act.
Visitors to the INFU news page can review this stream of financial updates, guidance, leadership announcements, conference participation notices and regulatory disclosures to understand how the company describes its performance and strategic priorities over time.
InfuSystem Holdings, Inc. (NYSE American: INFU) announced a new $75 million revolving credit facility with JPMorgan Chase Bank, replacing a $49 million facility. Effective February 5, 2021, this facility enhances liquidity and financial flexibility, allowing the company to capitalize on growth opportunities in Integrated Therapy Services and Durable Medical Equipment Services. With this facility, InfuSystem's liquidity increases to over $45 million from approximately $20 million previously. The facility features a five-year term and an interest rate tied to the company's Total Leverage Ratio.
InfuSystem Holdings, Inc. (NYSE American: INFU) has announced the acquisition of FilAMed, a biomedical services company based in Bakersfield, CA. Although the terms of the transaction were not disclosed, CEO Richard DiIorio emphasized the strategic importance of this acquisition in expanding InfuSystem's capabilities within its Durable Medical Equipment Services (DME) platform. The acquisition aims to enhance service offerings such as compression devices and patient monitors, while providing a broader range of services and facilitating entry into the acute care market.
InfuSystem Holdings, Inc. (NYSE: INFU) has announced its financial guidance for 2021, projecting net revenues of $107 million to $110 million, Adjusted EBITDA of $29 million to $30 million, and operating cash flow of $21 million to $23 million. Management anticipates strong growth driven by its Integrated Therapy Services (ITS) Segment, particularly in Pain Management and Negative Pressure Wound Therapy. Despite expecting tailwinds from COVID-19, they remain cautious about potential impacts on operations.
InfuSystem Holdings, Inc. (NYSE American: INFU) will be participating in the 13th Annual LD Micro Main Event on December 15, 2020, at 3:00 p.m. ET. The presentation will be conducted virtually by CEO Rich DiIorio and CFO Barry Steele.
InfuSystem is a prominent health care service provider specializing in outpatient care for durable medical equipment. The company operates through two platforms: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services), servicing areas including Oncology, Pain Management, and Wound Therapy.
InfuSystem Holdings, Inc. (NYSE American: INFU) will announce its full year 2021 annual financial guidance on December 15, 2020, prior to market opening. A conference call for investors will occur at 9:00 a.m. Eastern Time on the same day to discuss the guidance and business developments. Interested participants can join via phone or through a live webcast on the company’s website. InfuSystem specializes in providing outpatient care solutions for manufacturers and healthcare providers under two platforms: Integrated Therapy Services and Durable Medical Equipment Services.
InfuSystem Holdings, a prominent health care service provider, announced that CEO Rich DiIorio and CFO Barry Steele will present at key investor conferences on November 17 and 19, 2020. The conferences include the Craig-Hallum Capital Group 11th Annual Alpha Select Conference and the Sidoti & Company Virtual Microcap Conference. A presentation at the latter is scheduled for 2:30 p.m. ET, with a webcast available on InfuSystem's investor relations website. The company focuses on outpatient care for durable medical equipment, serving sectors like oncology and pain management.
InfuSystem Holdings reported robust Q3 2020 financial results, with net revenues of $25.1 million, representing a 17% increase compared to the previous year. Net income surged by 159% to $2.9 million, while Adjusted EBITDA rose 46% to $7.5 million. The company has raised its full-year guidance to estimated revenues of $96 million - $97 million and Adjusted EBITDA of $26 million - $27 million. Strong performance was driven by increased demand in oncology and a growing market for infusion pumps due to COVID-19, leading to improved operating cash flow and profitability.
InfuSystem Holdings, Inc. (NYSE American: INFU) will release its third quarter 2020 financial results on November 12, 2020, before market opening. The company will host a conference call for investors at 9:00 a.m. Eastern Time on the same day to discuss the results. Interested participants can join via phone or a live webcast available on the company’s website. InfuSystem specializes in outpatient care, particularly through its Integrated Therapy Services and Durable Medical Equipment Services platforms.
InfuSystem Holdings to Present at Sidoti’s Fall 2020 Investor Conference
Rochester Hills, Michigan, Sept. 14, 2020 – InfuSystem (NYSE American: INFU) announced that CEO Richard DiIorio and CFO Barry Steele will present at Sidoti's Fall 2020 Investor Conference on September 23 at 3:15 p.m. ET via a virtual platform. The presentation will be available on InfuSystem's website. Additionally, the management will hold one-on-one meetings with investors on September 23-24. InfuSystem is a prominent national health care service provider, specializing in outpatient care for durable medical equipment.
InfuSystem Holdings, a national health care service provider focused on outpatient care, announced CEO Richard DiIorio and CFO Barry Steele will present at Lake Street's 4th Annual Best Ideas Growth (BIG4) Conference on September 17, 2020. The event will be held virtually, featuring one-on-one and group meetings with investors throughout the day. InfuSystem operates through Integrated Therapy Services and Durable Medical Equipment Services, ensuring comprehensive support for durable medical equipment.